Loading...
XSTO
OSSD
Market cap141mUSD
Jun 05, Last price  
14.00SEK
1D
0.14%
1Q
15.70%
IPO
-39.13%
Name

OssDsign AB

Chart & Performance

D1W1MN
P/E
P/S
10.21
EPS
Div Yield, %
Shrs. gr., 5y
37.18%
Rev. gr., 5y
51.34%
Revenues
134m
+19.42%
4,194,9667,682,00013,264,00016,873,00024,872,00031,726,00056,985,000112,157,000133,940,000
Net income
-50m
L-61.95%
-28,514,666-63,272,000-56,011,000-84,245,000-84,590,000-93,918,000-99,387,000-130,493,000-49,657,000
CFO
-62m
L-33.58%
-40,613,000-66,052,000-86,593,000-79,098,000-89,784,000-89,229,000-93,909,000-62,379,000
Earnings
Aug 18, 2025

Profile

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
IPO date
May 24, 2019
Employees
50
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
133,940
19.42%
112,157
96.82%
56,985
79.62%
Cost of revenue
180,966
202,289
129,414
Unusual Expense (Income)
NOPBT
(47,026)
(90,132)
(72,429)
NOPBT Margin
Operating Taxes
573
(162)
(242)
Tax Rate
NOPAT
(47,599)
(89,970)
(72,187)
Net income
(49,657)
-61.95%
(130,493)
31.30%
(99,387)
5.82%
Dividends
Dividend yield
Proceeds from repurchase of equity
(967)
149,999
66,074
BB yield
0.10%
-22.81%
-19.37%
Debt
Debt current
933
1,334
3,094
Long-term debt
2,783
4,239
22,866
Deferred revenue
Other long-term liabilities
57,480
52,698
46,950
Net debt
(97,142)
(160,365)
(101,197)
Cash flow
Cash from operating activities
(62,379)
(93,909)
(89,229)
CAPEX
(657)
(124)
(129)
Cash from investing activities
(657)
(124)
(129)
Cash from financing activities
(2,465)
135,395
61,843
FCF
(56,726)
(78,885)
(71,377)
Balance
Cash
100,858
165,938
124,653
Long term investments
2,504
Excess cash
94,161
160,330
124,308
Stockholders' equity
(613,335)
(545,538)
(431,758)
Invested Capital
886,842
852,518
718,944
ROIC
ROCE
EV
Common stock shares outstanding
99,314
82,201
58,603
Price
9.86
23.25%
8.00
37.46%
5.82
-33.10%
Market cap
979,236
48.91%
657,608
92.81%
341,072
-19.01%
EV
882,094
497,243
239,875
EBITDA
(47,026)
(65,780)
(62,711)
EV/EBITDA
Interest
3,738
9,428
Interest/NOPBT